Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582309 · ClinicalTrials.gov registry record · NA
Comparative Trial Between 3 Types of Insulin Infusion Protocols
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT00582309: Completed NA study, sponsored by University of New Mexico.
NCT00582309 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582309, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
Increasing evidence from observational studies in hospitalized patients with and without diabetes indicates that hyperglycemia is a predictor of poor outcome. Over the short-term, hyperglycemia can adversely affects fluid balance (through glycosuria and dehydration), impairs immunologic response to infection, and promotes inflammation and endothelial dysfunction. Blood glucose control with intensive insulin therapy in patients with acute critical illness reduces the risk of multiorgan failure and systemic infections, and decreases short- and long-term mortality . \- Hypotheses: we hypothesize that management of inpatient hyperglycemia with a computer-guided intravenous infusion protocol (Glucommander) will facilitate a smoother glycemic control with a lower rate of hypoglycemic events than treatment following a standard insulin infusion algorithm or a simple calculated infusion protocol in critically ill patients in the medical and surgical ICU.
Primary Outcome
The protocol were compared by measuring in each patient time to acquire the Blood Glucose (BG) target range (80-120 mg/dl) defined by reaching a BG \< 120, and maintaining the target range thereafter.
Interventions
- PROCEDURE Glucommander-Guided Intravenous Insulin Infusion
- PROCEDURE Standard Intravenous Insulin Infusion
- PROCEDURE Simple Calculated Intravenous Insulin Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00582309 record still lists
NCT00582309 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Glucommander-Guided Intravenous Insulin Infusion is the first listed.
NCT00582309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582309 about?
NCT00582309 is a clinical study titled "Comparative Trial Between 3 Types of Insulin Infusion Protocols". Increasing evidence from observational studies in hospitalized patients with and without diabetes indicates that hyperglycemia is a predictor of poor outcome. Over the short-term, hyperglycemia can adversely affects fluid balance (through glycosuria and dehydration), impairs immunologic response to ...
What is the current status of trial NCT00582309?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2007-08. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00582309?
The interventions under investigation include: Glucommander-Guided Intravenous Insulin Infusion (PROCEDURE), Standard Intravenous Insulin Infusion (PROCEDURE), Simple Calculated Intravenous Insulin Infusion (PROCEDURE).
Who is sponsoring clinical trial NCT00582309?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00582309's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia